Phase 2 Study of Efficacy and Safety of AK120, in Subjects With Moderate-to-Severe Atopic Dermatitis
Clinical trial NCT05048056 · TERMINATED
Trial details
- NCT number
- NCT05048056
- Sponsor
- Akesobio Australia Pty Ltd
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-09-30
- Primary completion
- 2023-05-17
- Enrollment
- 79
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.